Agios Reports Phase III Success With Oral Drug For Thalassemia

 
• By Jessica Merrill
  
target
Agios hit the mark in a Phase III trial in thalassemia. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D